MicroRNAs and cancer - PubMed (original) (raw)
Review
. 2008 Apr;263(4):366-75.
doi: 10.1111/j.1365-2796.2008.01926.x. Epub 2008 Feb 20.
Affiliations
- PMID: 18298485
- DOI: 10.1111/j.1365-2796.2008.01926.x
Free article
Review
MicroRNAs and cancer
T Dalmay. J Intern Med. 2008 Apr.
Free article
Abstract
The Nobel Prize in Medicine and Physiology was awarded to the RNA interference (RNAi) field in 2006 because of the huge therapeutic potential this technique harbours. However, the RNAi technology is based on a natural mechanism that utilizes short noncoding RNA molecules (microRNAs) to regulate gene expression. This paper reviews our current knowledge about microRNAs focusing on their involvement in cancer and their potential as diagnostics and therapeutics.
Similar articles
- Potential use of RNA interference in cancer therapy.
Phalon C, Rao DD, Nemunaitis J. Phalon C, et al. Expert Rev Mol Med. 2010 Aug 18;12:e26. doi: 10.1017/S1462399410001584. Expert Rev Mol Med. 2010. PMID: 20716384 Review. - MicroRNAs in clinical oncology: at the crossroads between promises and problems.
Metias SM, Lianidou E, Yousef GM. Metias SM, et al. J Clin Pathol. 2009 Sep;62(9):771-6. doi: 10.1136/jcp.2009.064717. J Clin Pathol. 2009. PMID: 19734473 Review. - [RNA interference and molecular pathology of selected diseases].
Lochmanová J, Bartos M. Lochmanová J, et al. Cas Lek Cesk. 2008;147(12):607-15. Cas Lek Cesk. 2008. PMID: 19235485 Review. Czech. - RNA interference: natural, experimental, and clinical roles in cancer biology.
Mroz EA, Rocco JW. Mroz EA, et al. Head Neck. 2006 Dec;28(12):1132-41. doi: 10.1002/hed.20439. Head Neck. 2006. PMID: 16823868 Review. - [MiRNA in disease and therapeutic development].
Tanaka Y, Kozu T. Tanaka Y, et al. Tanpakushitsu Kakusan Koso. 2006 Dec;51(16 Suppl):2509-14. Tanpakushitsu Kakusan Koso. 2006. PMID: 17471971 Review. Japanese. No abstract available.
Cited by
- Patterns of microRNA expression in non-human primate cells correlate with neoplastic development in vitro.
Teferedegne B, Murata H, Quiñones M, Peden K, Lewis AM. Teferedegne B, et al. PLoS One. 2010 Dec 22;5(12):e14416. doi: 10.1371/journal.pone.0014416. PLoS One. 2010. PMID: 21203544 Free PMC article. - The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo.
Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC. Huse JT, et al. Genes Dev. 2009 Jun 1;23(11):1327-37. doi: 10.1101/gad.1777409. Genes Dev. 2009. PMID: 19487573 Free PMC article. - Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas.
Huskova H, Korecka K, Karban J, Vargova J, Vargova K, Dusilkova N, Trneny M, Stopka T. Huskova H, et al. Int J Hematol. 2015 Oct;102(4):441-50. doi: 10.1007/s12185-015-1847-4. Epub 2015 Aug 11. Int J Hematol. 2015. PMID: 26261072 - Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Löb S, Königsrainer A, Rammensee HG, Opelz G, Terness P. Löb S, et al. Nat Rev Cancer. 2009 Jun;9(6):445-52. doi: 10.1038/nrc2639. Nat Rev Cancer. 2009. PMID: 19461669 Review. - Biological effects of RNAi targeted inhibiting Tiam1 gene expression on cholangiocarcinoma cells.
Cheng W, Liu Y, Zuo Z, Yin X, Jiang B, Chen D, Peng C, Yang J. Cheng W, et al. Int J Clin Exp Pathol. 2015 Dec 1;8(12):15511-26. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26884821 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources